Chemotherapy-radiation interactions in human cervix carcinoma xenografts
1988

Chemotherapy and Radiation Interactions in Cervical Cancer

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): K.S. Tonkin, L.R. Kelland, G.G. Steel

Primary Institution: Institute of Cancer Research

Hypothesis

Can chemotherapy improve tumor growth delay when combined with low dose-rate radiation in cervical cancer treatment?

Conclusion

Ifosfamide combined with low dose-rate radiation significantly increased tumor growth delay compared to radiation alone.

Supporting Evidence

  • Ifosfamide combined with low dose-rate radiation resulted in a specific growth delay of 10.
  • Radiation alone resulted in a specific growth delay of 2.3.
  • High dose-rate radiation with ifosfamide did not improve tumor growth delay compared to radiation alone.

Takeaway

This study found that using a drug called ifosfamide with low dose radiation helps slow down cancer growth better than radiation alone.

Methodology

The study used human cervix carcinoma xenografts in nude mice to evaluate the effects of chemotherapy agents combined with low dose-rate radiation.

Limitations

The study was conducted in a mouse model, which may not fully replicate human responses.

Participant Demographics

Nude mice were used for the xenograft experiments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication